| Application no. and date | 17772258.4 (espacenet) (Federated) (European Patent Register), 20170914 | | Patent/reg. no. and date | DK/EP 3512547, 20201111 | | Publication date | 20190724 | | Priority no. and date | US 201662394314 P, 20160914 | | EP pub. no. and date |
EP 3512547 20190724 | | Effective date | | | Applicant/owner | AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard
Redwood City, CA 94063, US | | Applicant ref. no. | V2011-058-DK | | Inventor | AFAR, Daniel E. H., 12682 Roble Veneno Lane
Los Altos Hills
California 94022, US,
HARDING, Fiona A., 543 Calderon Avenue
Mountain View
California 94041, US,
SAMAYOA, Josue, 806 E. 16th Avenue
San Mateo
California 94402, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , A61P 37/04 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-PD-1-ANTISTOFFER | | Int. application no. | US2017051531 | | Int. publication no. | WO2018053106 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
